Requirement of Vascular Integrin α v β 3 for Angiogenesis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin α v β 3 was identified as a marker of angiogenic vascular tissue. Integrin α v β 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to α v β 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-α, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that α v β 3 may be a useful therapeutic target for diseases characterized by neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the integrin a v b 3 is expressed on blood vessels in human wound granulation tissue but not in normal skin”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
In the citing paper
“antibodies against this integrin block angiogenesis induced by FGF and TNF-a without affecting preexisting blood vessels”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationCell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
Adams, J. C., & Watt, F. M. (1990) · Cell · doi:10.1016/0092-8674(90)90175-e · Cited by 448
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationLeavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Self-citationInvolvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., & Cheresh, D. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115811 · Cited by 378
Self-citation
Research works printed but not linked: 1
- FOLKMAN, J, SEMINARS CANCER BIOL 3: 65 (1992).
Cited by
Items 601–700 of 1,011
Cyclic RGD Peptides Containing β-Turn Mimetics
Haubner, R., Schmitt, W., Hölzemann, G., Goodman, S. L., Jonczyk, A., & Kessler, H. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9608757 · Cited by 135
Integrins: Signaling, disease, and therapy
Huveneers, S., Truong, H. H., & Danen, E. H. J. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701481808 · Cited by 135
Clark, R. A. F. (1988) · Springer eBooks · doi:10.1007/978-1-4899-0185-9_1 · Cited by 135
Self-citationMultimodality Cardiovascular Molecular Imaging, Part II
Nahrendorf, M., Sosnovik, D. E., French, B. A., Swirski, F. K., Bengel, F., Sadeghi, M. M., Lindner, J. R., Wu, J. C., Kraitchman, D. L., Fayad, Z. A., et al. (2009) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.108.839092 · Cited by 135
Lode, H. N., Moehler, T. M., Xiang, R., Jonczyk, A., Gillies, S. D., Cheresh, D. A., & Reisfeld, R. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1591 · Cited by 135
Self-citationGe, Z., Chen, Q., Osada, K., Liu, X., Tockary, T. A., Uchida, S., Dirisala, A., Ishii, T., Nomoto, T., Toh, K., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.086 · Cited by 134
Lei, H., An, P., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., Lin, M., Meisheng, L., Junshan, Y., & Chengchao, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203103200 · Cited by 134
Frangogiannis, N. G., Mendoza, L. H., Lewallen, M., Michael, L. H., Smith, C. W., & Entman, M. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0745fje · Cited by 134
Wang, J., & Milner, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03521.x · Cited by 134
Ebeling, O., Duczmal, A., Aigner, S., Geiger, C., Schöllhammer, S., Kemshead, J. T., Mӧller, P., Schwartz‐Albiez, R., & Altevogt, P. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261035 · Cited by 134
Serum Soluble Vascular Cell Adhesion Molecule-1: Role as a Surrogate Marker of Angiogenesis
Byrne, G. J., Ghellal, A., Iddon, J., Blann, A. D., Venizelos, V., Kumar, S., Howell, A., & Bundred, N. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1329 · Cited by 134
Radiometallated peptides for molecular imaging and targeted therapy
Correia, J. D. G., Paulo, A., Raposinho, P., & Santos, I. (2011) · Dalton Transactions · doi:10.1039/c0dt01599g · Cited by 134
Approaches to studying cell adhesion molecules in angiogenesis
Bischoff, J. E. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88949-7 · Cited by 133
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
Yang, Y., MacLeod, V., Dai, Y., Khotskaya-Sample, Y., Shriver, Z., Venkataraman, G., Sasisekharan, R., Naggi, A., Torri, G., Casu, B., et al. (2007) · Blood · doi:10.1182/blood-2007-04-082495 · Cited by 133
Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis
Creamer, D., Allen, M. H., Sousa, A. R., Poston, R. N., & Barker, J. N. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.01845.x · Cited by 133
Liu, W. F., Nelson, C. M., Tan, J. L., & Chen, C. S. (2007) · Circulation Research · doi:10.1161/circresaha.107.158329 · Cited by 133
Reynolds, A. R. (2010) · Dose-Response · doi:10.2203/dose-response.09-049.reynolds · Cited by 133
Focally regulated endothelial proliferation and cell death in human synovium.
Walsh, D. A., Wade, M., Mapp, P. I., & Blake, D. R. (1998) · Europe PMC (PubMed Central) · Cited by 133
Overview: Studying Integrins In Vivo
Lowell, C. A., & Mayadas, T. N. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-166-6_22 · Cited by 133
The functional role of cell adhesion molecules in tumor angiogenesis
Francavilla, C., Maddaluno, L., & Cavallaro, U. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.004 · Cited by 133
Regulation of Tumor Angiogenesis by Dietary Fatty Acids and Eicosanoids
Rose, D. P., & Connolly, J. M. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc372_1 · Cited by 132
Interleukin-15 Promotes Angiogenesisin Vivo
Angiolillo, A. L., Kanegane, H., Sgadari, C., Reaman, G. H., & Tosato, G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6435 · Cited by 132
Teicher, B. A. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437479 · Cited by 132
Barillari, G., & Ensoli, B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.310-326.2002 · Cited by 132
The interaction between urokinase receptor and vitronectin in cell adhesion and signalling
Madsen, C. D., & Sidénius, N. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.02.003 · Cited by 132
Wu, Z., Li, Z., Cai, W., He, L., Chin, F. T., Li, F., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0427-0 · Cited by 132
Review of Integrin‐Targeting Biomaterials in Tissue Engineering
Dhavalikar, P., Robinson, A., Lan, Z., Jenkins, D. M. R., Chwatko, M., Salhadar, K., Jose, A., Kar, R., Shoga, E., Kannapiran, A., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000795 · Cited by 132
Targeting of proangiogenic signalling pathways in chronic inflammation
Tas, S. W., Maracle, C. X., Balogh, E., & Szekanecz, Z. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.164 · Cited by 132
Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage
Yougbaré, I., Lang, S., Yang, H., Chen, P., Zhao, X., Tai, W.-S., Zdravic, D., Vadasz, B., Li, C., Piran, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77820 · Cited by 132
Proteases and Glioma Angiogenesis
Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00118.x · Cited by 131
Imaging Metastasis Using an Integrin-Targeting Chain-Shaped Nanoparticle
Peiris, P. M., Toy, R., Doolittle, E., Pansky, J., Abramowski, A., Tam, M., Vicente, P., Tran, E., Hayden, E., Camann, A., et al. (2012) · ACS Nano · doi:10.1021/nn303833p · Cited by 131
Is endometriosis an endometrial disease?
Vinatier, D., Cosson, M., & Dufour, P. (2000) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(99)00263-8 · Cited by 131
Woods, D., Cherwinski, H., Venetsanakos, E., Bhat, A., Gysin, S., Humbert, M., Bray, P. F., Saylor, V. L., & McMahon, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3192-3205.2001 · Cited by 131
Adhesion molecules as determinants of disease: From molecular biology to surgical research
Menger, M. D., & Vollmar, B. (1996) · British journal of surgery · doi:10.1002/bjs.1800830506 · Cited by 131
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule‐dependency
Mikkelsen, T., Brodie, C., Finniss, S., Berens, M. E., Rennert, J. L., Nelson, K., Lemke, N., Brown, S. L., Hahn, D., Neuteboom, B., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24240 · Cited by 131
Integrins in Vascular Development
Rupp, P. A., & Little, C. D. (2001) · Circulation Research · doi:10.1161/hh1901.097747 · Cited by 131
Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.
Bach‐Gansmo, T., Danielsson, R., Saracco, A., Wilczek, B., Bogsrud, T. V., Fangberget, A., Tangerud, Å., & Tobin, D. (2006) · PubMed · Cited by 131
Therapeutic targeting of the prostate cancer microenvironment
Κάρλου, Μ., Tzelepi, V., & Efstathiou, E. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.134 · Cited by 131
A Role for the αvβ3 Integrin in the Transmigration of Monocytes
Weerasinghe, D., McHugh, K. P., Ross, F. P., Brown, E. J., Gisler, R. H., & Imhof, B. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.595 · Cited by 130
“The integrin is also upregulated on proliferating endothelial cells (24), and initiates a Ca12-dependent signaling pathway that leads to endothelial cell migration and the process of angiogenesis (6, 42).”
BackgroundAngiogenesis blockade as a new therapeutic approach to experimental colitis
Danese, S., Sans, M., Spencer, D. M., Beck, I., Doñate, F., Plunkett, M. L., de la Motte, C., Redline, R., Shaw, D. E., Levine, A. D., et al. (2007) · Gut · doi:10.1136/gut.2006.114314 · Cited by 130
Discovery of Small Molecule Integrin αvβ3 Antagonists as Novel Anticancer Agents
Dayam, R., Aiello, F., Deng, J. N., Wu, Y., Garofalo, A., Chen, X. S., & Neamati, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051296s · Cited by 130
García, J. R., Clark, A. Y., & García, A. J. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35626 · Cited by 130
Discovery of Potent Nonpeptide Vitronectin Receptor (αVβ3) Antagonists
Keenan, R. M., Miller, W. H., Kwon, C., Ali, F. E.-F., Callahan, J. F., Calvo, R. R., Hwang, S. M., Kopple, K. D., Peishoff, C. E., Samanen, J. M., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970205r · Cited by 130
Atomic force microscopy measurement of leukocyte-endothelial interaction
Zhang, X. H., Chen, A. B., Leon, D. D., Li, H., Noiri, E., Moy, V. T., & Goligorsky, M. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00491.2003 · Cited by 129
The Cell Adhesion Domain in Plasma Vitronectin Is Cryptic
Seiffert, D., & Smith, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13705 · Cited by 129
Sun, M., Opavsky, M. A., Stewart, D. J., Rabinovitch, M., Dawood, F., Wen, W.-H., & Liu, P. P. (2003) · Circulation · doi:10.1161/01.cir.0000051363.86009.3c · Cited by 129
Iervolino, A., Trisciuoglio, D., Ribatti, D., Candiloro, A., Biroccio, A., Zupi, G., & Del Bufalo, D. (2002) · The FASEB Journal · doi:10.1096/fj.02-0122fje · Cited by 129
Molecular and cellular biology of osteopontin
Giachelli, C. M., Schwartz, S. M., & Liaw, L. (1995) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(95)00005-t · Cited by 129
Bello, L., Lucini, V., Carrabba, G. G., Giussani, C. G., Machluf, M., Pluderi, M., Nikas, D. L., Zhang, J., Tomei, G., Villani, R. M., et al. (2001) · PubMed · Cited by 129
Peptide Receptor Radionuclide Therapy: An Overview
Dash, A., Chakraborty, S., Pillai, M. R. A., & Knapp, F. F. (. (2015) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1741 · Cited by 128
Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancer
Sachs, M. D., Rauen, K. A., Ramamurthy, M., Dodson, J. L., Marzo, A. M. D., Putzi, M. J., Schoenberg, M., & Rodríguez, R. (2002) · Urology · doi:10.1016/s0090-4295(02)01748-x · Cited by 128
Feng, X., Clark, R. A. F., Galanakis, D. K., & Tonnesen, M. G. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00786.x · Cited by 128
Self-citationIntegrins in vascular development
Hynes, R. O., Bader, B. L., & Hodivala-Dilke, K. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000500002 · Cited by 128
The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery
Zhan, C., & Lu, W. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112803341798 · Cited by 128
Battle, M. R., Goggi, J., Allen, L., Barnett, J., & Morrison, M. S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077479 · Cited by 128
Yeh, C., Peng, H., Yang, R., & Huang, T. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1333 · Cited by 128
Boudreau, N. J., & Varner, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305190200 · Cited by 127
Increased tumor cell dissemination and cellular senescence in the absence of β1‐integrin function
Kren, A., Baeriswyl, V., Lehembre, F., Wunderlin, C., Strittmatter, K., Antoniadis, H., Fässler, R., Cavallaro, U., & Christofori, G. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601738 · Cited by 127
Clinical significance of determination of surrogate markers of angiogenesis in breast cancer
Gasparini, G. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00105-0 · Cited by 127
In vivo monitoring of tumor angiogenesis with MR imaging
Brasch, R. C., Li, K. C., Husband, J. E., Keogan, M. T., Neeman, M., Padhani, A. R., Shames, D. M., & Turetschek, K. (2000) · Academic Radiology · doi:10.1016/s1076-6332(00)80630-3 · Cited by 127
Angiogenic effects of ionic dissolution products released from a boron-doped 45S5 bioactive glass
Durand, L. A. H., Vargas, G. E., Romero, N. M., Mesones, R. V., López, J. M. P., Boccaccini, A. R., Zago, M. P., Baldi, A., & Gorustovich, A. A. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01840k · Cited by 127
Oliveira‐Ferrer, L., Hauschild, J., Fiedler, W., Bokemeyer, C., Nippgen, J., Çelik, İ., & Schuch, G. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-86 · Cited by 126
Chen, S., Yang, K., Tuguntaev, R. G., Mozhi, A., Zhang, J., Wang, P. C., & Liang, X.-J. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.020 · Cited by 126
Vailhé, B., Ronot, X., Tracqui, P., Usson, Y., & Tranqui, L. (1997) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-997-0155-6 · Cited by 126
Radionuclide carriers for targeting of cancer
Sofou, S. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2736 · Cited by 126
Lissitzky, J., Luis, J., Munzer, J. S., Benjannet, S., PARAT, F., Chrétien, M., Marvaldi, J. L., & Seidah, N. G. (2000) · Biochemical Journal · doi:10.1042/bj3460133 · Cited by 126
Fåhræus, R., & Lane, D. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2106 · Cited by 125
Funahashi, Y., Sugi, N. H., Semba, T., Yamamoto, Y., Hamaoka, S., Tsukahara-Tamai, N., Ozawa, Y., Tsuruoka, A., Nara, K., Takahashi, K., et al. (2002) · PubMed · Cited by 125
A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis
Harms, J. F., Welch, D. R., Samant, R. S., Shevde, L. A., Miele, M. E., Babu, G. R., Goldberg, S. F., Gilman, V. R., Sosnowski, D. M., Campo, D. A., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024763.69809.64 · Cited by 125
Friess, H., Langrehr, J. M., Oettle, H., Raedle, J., Niedergethmann, M., Dittrich, C., Hossfeld, D. K., Stöger, H., Neyns, B., Herzog, P., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-285 · Cited by 125
Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis
Doolittle, E., Peiris, P. M., Doron, G., Goldberg, A., Tucci, S., Rao, S., Shah, S., Sylvestre, M., Govender, P., Turan, O., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b01552 · Cited by 125
The role of angiogenesis in rheumatoid arthritis: recent developments
Koch, A. E. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i65 · Cited by 125
Vascular development and disorders: Molecular analysis and pathogenic insights
Carmeliet, P., & Collen, D. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00936.x · Cited by 125
Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ3
Lakshmikanthan, S., Sobczak, M., Chun, C., Henschel, A., Dargatz, J., Ramchandran, R., & Chrzanowska‐Wodnicka, M. (2011) · Blood · doi:10.1182/blood-2011-04-349282 · Cited by 125
Davis, G. E., Koh, W., & Stratman, A. N. (2007) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20107 · Cited by 125
Dayton, P. A., Pearson, D., Clark, J., Simon, S. I., Schumann, P. A., Zutshi, R., Matsunaga, T. O., & Ferrara, K. W. (2004) · Molecular Imaging · doi:10.1162/1535350041464883 · Cited by 125
Piard, C., Jeyaram, A., Liu, Y., Caccamese, J. F., Jay, S. M., Chen, Y., & Fisher, J. P. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119423 · Cited by 125
Parker, B. L., Palmisano, G., Edwards, A. V. G., White, M. Y., Engholm‐Keller, K., Lee, A., Scott, N. E., Kolarich, D., Hambly, B. D., Packer, N. H., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.006833 · Cited by 125
Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation
Schleich, N., Danhier, F., & Préat, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.024 · Cited by 124
“Interestingly, integrin αvβ3 has been shown to be overexpressed on both neoangiogenic endothelial cells and on the surface of many tumor cell types [19,51].”
BackgroundPeptide Ligands for Integrin .alpha.v.beta.3 Selected from Random Phage Display Libraries
Healy, J. M., Murayama, O., Maeda, T., Yoshino, K., Sekiguchi, K., & Kikuchi, M. (1995) · Biochemistry · doi:10.1021/bi00012a012 · Cited by 124
Microvascular Responses to Cerebral Ischemia/Inflammationa
del ZOPPO, G. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48386.x · Cited by 124
Swenson, S. D., Costa, F. K., Minea, R. O., Sherwìn, R. P., Ernst, W. A., Fujii, G., Yang, D., & Markland, F. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.499.3.4 · Cited by 124
Current Status Of Burn Wound Pathophysiology
Gibran, N. S., & Heimbach, D. M. (2000) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)32680-8 · Cited by 124
Matrix Metalloproteinases: Pro- and Anti-Angiogenic Activities
Raza, S. L., & Cornelius, L. A. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00004.x · Cited by 123
Angiogenesis in cancer: Anti-VEGF escape mechanisms.
Prager, G. W., Poettler, M., Unseld, M., & Zielinski, C. C. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2011.11.02 · Cited by 123
New Multifunctional Molecular Conjugate Vector for Targeting, Imaging, and Therapy of Tumors
Garanger, É., Boturyn, D., Jin, Z.-H., Dumy, P., Favrot, M., & Coll, J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.095 · Cited by 123
Buerkle, M. A., Pahernik, S. A., Sutter, A., Jonczyk, A., Messmer, K., & Dellian, M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600141 · Cited by 123
Venetsanakos, E., Mirza, A. M., Fanton, C. P., Romanov, S. R., Tlsty, T. D., & McMahon, M. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5424 · Cited by 123
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
Passalidou, E., Trivella, M., Singh, N., Ferguson, M., Hu, J., Cesario, A., Granone, P., Nicholson, A. G., Goldstraw, P., Ratcliffe, C., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600015 · Cited by 123
Endothelial Cell VE-cadherin Functions as a Receptor for the β15–42 Sequence of Fibrin
Bach, T. L., Barsigian, C., Yaen, C. H., & Martinez, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30719 · Cited by 123
Liao, F., Doody, J. F., Overholser, J. P., Finnerty, B., Bassi, R., Wu, Y. L., Dejana, E., Kussie, P. H., Böhlen, P., & Hicklin, D. J. (2002) · PubMed · Cited by 123
Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches
van Moorselaar, R. J. A., & Voest, E. E. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00262-9 · Cited by 123
Growth factor signaling pathways in vascular development
Tallquist, M. D., Soriano, P. M., & Klinghoffer, R. A. (1999) · Oncogene · doi:10.1038/sj.onc.1203216 · Cited by 123
Endothelial cell–Matrix interactions
Iivanainen, E., Kähäri, V., Heino, J., & Elenius, K. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10238 · Cited by 122
Involvement of Endothelial Nitric Oxide in Sphingosine-1-Phosphate–Induced Angiogenesis
Rikitake, Y., Hirata, K.-I., Kawashima, S., Ozaki, M., Takahashi, T., Ogawa, W., Inoue, N., & Yokoyama, M. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.101843 · Cited by 122
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model
Xu, H., Lui, W. T., Chu, C. Y., Ng, P. S., Wang, C. C., & Rogers, M. S. (2008) · Human Reproduction · doi:10.1093/humrep/den417 · Cited by 122
Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia.
Okada, Y., Copeland, B. R., Hamann, G. F., Koziol, J. A., Cheresh, D. A., & del Zoppo, G. J. (1996) · Europe PMC (PubMed Central) · Cited by 122
Self-citationThe role of the microenvironment and intercellular cross-talk in tumor angiogenesis
Ahmad, S. A., Jung, Y. D., Liu, W., Reinmuth, N., Parikh, A. A., Stoeltzing, O., Fan, F., & Ellis, L. M. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0418 · Cited by 122
Tumor angiogenesis as a therapeutic target
Matter, A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01939-0 · Cited by 122
A novel disintegrin salmosin inhibits tumor angiogenesis.
Kang, I., Lee, Y., & Kim, D. (1999) · PubMed · Cited by 122
Metadata
- Authors
- Brooks, P. C., Clark, R. A. F., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Stony Brook University (US)
- Venue
- Science
- Published
- 1994-04-22
- Volume
- 264
- Issue
- 5158
- Pages
- 569-571
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029773366
- Cited by
- 3,020
- References
- 22
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 50 · 2023: 36 · 2022: 57 · 2021: 60 · 2020: 54 · 2019: 60 · 2018: 69 · 2017: 62 · 2016: 91 · 2015: 74 · 2014: 102 · 2013: 124 · 2012: 104
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50286, CA-45726, R01CA045726)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, angiogenesis, chorioallantoic membrane, basic fibroblast growth factor, TNF-α, melanoma, monoclonal antibodies, neovascularization, therapeutic target
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Vessels, Chick Embryo, Granulation Tissue, Humans, Laminin, Melanoma, Neovascularization, Pathologic, Skin, Tumor Necrosis Factor-alpha, von Willebrand Factor, Integrins, Receptors, Cytoadhesin, Fibroblast Growth Factor 2, Receptors, Vitronectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.